This position paper presents facts and figures regarding the evolution of interactions between pharma companies and physicians, and makes practical recommendations to ensure regular and impactful interactions in the years to come
News
This new position paper analyses the current situation and the perspectives of therapeutic cannabis in France. To...
We are pleased to offer you this complete collection of 1,700+ pages, including 66 position papers and...
This new position paper highlights the role of Voluntary Trade Organizations (VTOs) in the French retail drug...